Antiretroviral therapy for children: Substantial benefit but limited access

JAMA

Volumn 296, Issue 3, 2006, Pages 330-331

  Harwell, Joseph I ^a   Obaro, Stephen K ^b  

^a MIRIAM HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTEREMIA; BACTERIAL PNEUMONIA; COHORT ANALYSIS; DRUG TOLERANCE; EDITORIAL; HAEMOPHILUS INFLUENZAE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MEDICAL LITERATURE; MYCOBACTERIUM INTRACELLULARE AVIUM; PNEUMOCYSTIS PNEUMONIA; PREGNANT WOMAN; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 33746032542     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.3.330     Document Type: Editorial

References (9)

1. UNAIDS. Report on the Global AIDS Epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2006.
2. Jean SS, Pape JW, Verdier RI, et al. The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J. 1999;18:58-63.
3. Meyers TM, Pettifor JM, Gray GE, Crewe-Brown H, Galpin JS. Pediatric admissions with human immunodeficiency virus infection at a regional hospital in Soweto, South Africa. J Trop Pediatr. 2000;46:224-230.
4. Bobat R, Moodley D, Coutsoudis A, Coovadia H, Gouws E. The early natural history of vertically transmitted HIV-1 infection in African children from Durban, South Africa. Ann Trop Paediatr. 1998;18:187-196.
5. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484-494.
6. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522-1528.
7. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194-200.
8. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296:292-300.
9. Taha TE, Graham SM, Kumwenda NI, et al. Morbidity among human immunodeficiency virus-1-infected and -uninfected African children [published online ahead of print]. Pediatrics. 2000;106:E77.